Sarah James
Stock Analyst at Cantor Fitzgerald
(2.12)
# 2,759
Out of 4,874 analysts
279
Total ratings
34.42%
Success rate
-3.11%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Reiterates: Neutral | $290 | $240.43 | +20.62% | 21 | May 1, 2025 | |
| ELV Elevance Health | Reiterates: Overweight | $485 | $374.99 | +29.34% | 20 | Apr 23, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $350 → $365 | $332.24 | +9.86% | 21 | Mar 20, 2025 | |
| TBRG TruBridge | Maintains: Overweight | $20 → $29 | $23.17 | +25.16% | 6 | Mar 11, 2025 | |
| LFMD LifeMD | Reiterates: Overweight | $15 | $13.31 | +12.70% | 11 | Mar 11, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $177 | $173.89 | +1.79% | 20 | Feb 13, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $405 | $380.60 | +6.41% | 19 | Jan 27, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $700 | $303.90 | +130.34% | 17 | Jan 17, 2025 | |
| CNC Centene | Reiterates: Overweight | $90 | $53.69 | +67.63% | 12 | Dec 11, 2024 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $21.88 | +137.66% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $17 | $21.64 | -21.44% | 14 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $219 | $179.85 | +21.77% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $406 | $292.24 | +38.93% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $21.89 | +96.44% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $3.75 | +326.67% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $68.19 | -9.07% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.68 | +197.62% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $8.66 | +15.54% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $98.03 | +3.03% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $140.30 | -5.20% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $22.21 | +89.10% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $3.94 | +26.90% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $4.83 | +3.52% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $13.73 | +53.01% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $57.65 | -32.34% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $73.11 | +163.99% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.58 | - | 2 | Mar 1, 2017 |
Humana
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $240.43
Upside: +20.62%
Elevance Health
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $374.99
Upside: +29.34%
The Cigna Group
Mar 20, 2025
Maintains: Overweight
Price Target: $350 → $365
Current: $332.24
Upside: +9.86%
TruBridge
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $23.17
Upside: +25.16%
LifeMD
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $13.31
Upside: +12.70%
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $173.89
Upside: +1.79%
HCA Healthcare
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $380.60
Upside: +6.41%
UnitedHealth Group
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $303.90
Upside: +130.34%
Centene
Dec 11, 2024
Reiterates: Overweight
Price Target: $90
Current: $53.69
Upside: +67.63%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $21.88
Upside: +137.66%
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $21.64
Upside: -21.44%
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $179.85
Upside: +21.77%
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $292.24
Upside: +38.93%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $21.89
Upside: +96.44%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $3.75
Upside: +326.67%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $68.19
Upside: -9.07%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.68
Upside: +197.62%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $8.66
Upside: +15.54%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $98.03
Upside: +3.03%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $140.30
Upside: -5.20%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $22.21
Upside: +89.10%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $3.94
Upside: +26.90%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $4.83
Upside: +3.52%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $13.73
Upside: +53.01%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $57.65
Upside: -32.34%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $73.11
Upside: +163.99%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.58
Upside: -